Divi's Laboratories (NSE:DIVISLAB) Total Liabilities : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Total Liabilities?

Divi's Laboratories's Total Liabilities for the quarter that ended in Dec. 2023 was ₹0 Mil.

Divi's Laboratories's quarterly Total Liabilities increased from Jun. 2023 (₹0.00 Mil) to Sep. 2023 (₹16,060.00 Mil) but then declined from Sep. 2023 (₹16,060.00 Mil) to Dec. 2023 (₹0.00 Mil).

Divi's Laboratories's annual Total Liabilities increased from Mar. 2021 (₹14,794.60 Mil) to Mar. 2022 (₹16,465.30 Mil) and increased from Mar. 2022 (₹16,465.30 Mil) to Mar. 2023 (₹16,716.80 Mil).

Divi's Laboratories Total Liabilities Historical Data

The historical data trend for Divi's Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Total Liabilities Chart

Divi's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

10,811.00

12,257.80

14,794.60

16,465.30

16,716.80

Divi's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															-	16,716.80	-	16,060.00	-

Divi's Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Divi's Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11010.8	+	(27.7	+	5372.1
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	306.2)
	=	16,717

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	144387.7	-	127670.9
	=	16,717

Divi's Laboratories's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	N/A	-	N/A
	=	N/A

Divi's Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories (NSE:DIVISLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Total Liabilities

Traded in Other Exchanges

532488:India

Address

Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines